Bal Pharma Ltd.

Financial

	Bal Pharma	Tyche Inds	Mangalam Drugs&Org.
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	1.06 %	1.28 %	3.31 %
Financials
5 yr Average ROE	8.41 %	14.86 %	7.15 %
5yr average Equity Multiplier	4.51	1.18	2.25
5yr Average Asset Turnover Ratio	1.01	0.6	1.24
5yr Avg Net Profit Margin	1.86 %	20.15 %	2.38 %
Price to Book	1.74	1.07	0.8
P/E	18.8	12.05	0.0
5yr Avg Cash Conversion Cycle	27.6 Days	86.71 Days	51.34 Days
Inventory Days	99.82 Days	61.45 Days	94.22 Days
Days Receivable	115.65 Days	108.17 Days	27.67 Days
Days Payable	154.91 Days	93.08 Days	84.69 Days
5yr Average Interest Coverage Ratio	1.5	2385.83	2.52
5yr Avg ROCE	19.2 %	19.65 %	15.15 %
5yr Avg Operating Profit Margin	9.12 %	23.57 %	9.09 %
5 yr average Debt to Equity	1.95	0.0	0.55
5yr CAGR Net Profit	8.78 %	-6.96 %	n/a
5yr Average Return on Assets	1.88 %	12.43 %	3.55 %
Shareholdings
Promoter Holding	50.86 %	61.97 %	50.3 %
Share Pledged by Promoters	0.0	0.0	13.23 %
Change in Promoter Holding (3 Yrs)	-1.14 %	0.0	-0.12 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bal Pharma	Tyche Inds	Mangalam Drugs&Org.
Product Wise Break-Up	Product Wise Break-Up Formulations 52.96 Active Pharmaceutical Ingredient (API) 43.44 Manufacture of bulk drugs intermediates 0 0 Others 3.6	Product Wise Break-Up Formulations 0 Bulk Chemicals 100.0 Active Pharmaceutical Ingredient (API) 0 0	Product Wise Break-Up Formulations 0 Manufacture of bulk drugs intermediates 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 64.15 India 35.85 International 0 Domestic 0	Location Wise Break-Up Rest of the World 0 India 0 Domestic 32.67 International 47.91 Others 19.42	Location Wise Break-Up Rest of the World 0 India 0 Domestic 62.61 International 37.39